Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
PeriPharm
The primary objective of this study is to estimate the productivity and activity impairment associated with migraine in adults treated with a triptan.
Participant identification will be made using pharmacies member of the PROxy Network. Eligible participants will be identified using the prescription of any formulation of triptans either when filling or refilling a prescription of a triptan or in the pharmacy electronic database (patients with a renewal in the last 3 months).
The PROxy Network is a research network bringing together community pharmacies across Quebec to facilitate the generation of real-world evidence. This network is designed to better understand a disease or a treatment using patient-reported outcomes (PROs). The PROxy Network is an initiative of PeriPharm Inc., a company specializing in pharmacoeconomics and outcomes research.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
18 years of age or older;
New or current prescription (renewal in the last 3 months) of any formulation of triptans medication (i.e., almotriptan, eletriptan, naratriptan, rizatriptan, sumatriptan, zolmitriptan and frovatriptan);
Working full or part-time or going to school full or part-time;
Ability to read and understand English or French;
Signature of informed consent form (ICF).
You may not be if
Patients participating in a clinical trial.
Patients filling a one-time vacation/emergency prescription (i.e. without a complete pharmacy file).
